In a filing, Bio-Techne Corp revealed its Chief Executive Officer Kelderman Kim unloaded Company’s shares for reported $1.04 million on Jan 27 ’25. In the deal valued at $77.29 per share,13,392 shares were sold. As a result of this transaction, Kelderman Kim now holds 39,004 shares worth roughly $2.83 million.
Then, KIM KELDERMAN bought 13,392 shares, generating $1,031,854 in total proceeds.
Before that, BAUMGARTNER ROBERT V sold 16,000 shares. Bio-Techne Corp shares valued at $1,153,664 were divested by the Director at a price of $72.10 per share. As a result of the transaction, BAUMGARTNER ROBERT V now holds 43,401 shares, worth roughly $3.15 million.
Citigroup downgraded its Bio-Techne Corp [TECH] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early February with a ‘”a Sector outperform”‘ rating. Stifel also remained covering TECH and has decreased its forecast on February 02, 2024 with a “Hold” recommendation from previously “Buy” rating. UBS started covering the stock on December 07, 2023. It rated TECH as “a Buy”.
Price Performance Review of TECH
On Tuesday, Bio-Techne Corp [NASDAQ:TECH] saw its stock jump 0.69% to $72.55. Over the last five days, the stock has lost -2.75%. Bio-Techne Corp shares have risen nearly 0.72% since the year began. Nevertheless, the stocks have risen 5.85% over the past one year. While a 52-week high of $85.57 was reached on 01/22/25, a 52-week low of $61.16 was recorded on 01/03/25. SMA at 50 days reached $74.40, while 200 days put it at $74.57.
Levels Of Support And Resistance For TECH Stock
The 24-hour chart illustrates a support level at 71.28, which if violated will result in even more drops to 70.00. On the upside, there is a resistance level at 74.31. A further resistance level may holdings at 76.06. The Relative Strength Index (RSI) on the 14-day chart is 43.70, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.45, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.78%. Stochastics %K at 21.56% indicates the stock is a holding.
How much short interest is there in Bio-Techne Corp?
A steep rise in short interest was recorded in Bio-Techne Corp stocks on 2025-01-15, growing by 0.54 million shares to a total of 4.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.51 million shares. There was a rise of 13.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 28, 2023 when William Blair began covering the stock and recommended ‘”an Outperform”‘ rating .
